CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- 4 Planned sale See remarks sold 6,205 shares at an average $49.94 ($309,850)
- 4 Planned sale See remarks sold 9,305 shares at an average $49.70 ($462,458)
- 4 Planned sale See remarks sold 6,200 shares at an average $48.13 ($298,437)
- 4 Planned sale See remarks sold 15,000 shares at an average $48.45 ($726,730)
- 4 Planned sale See remarks sold 6,205 shares at an average $49.15 ($305,000)
- 4 Planned sale See remarks sold 6,200 shares at an average $52.93 ($328,164)
- 4 Planned sale See remarks sold 3,100 shares at $56.11 ($173,944)
- 4 Option exercise President & CEO acquired 9,950 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale See remarks sold 9,000 shares at an average $39.25 ($353,291)
- 4 Option exercise See remarks acquired 16,505 shares (option exercise)
- 4 Option exercise President & CEO acquired 13,500 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 18,402 shares at an average $58.68 ($1,079,816)
- 4 Planned sale Director sold 15,625 shares at an average $58.00 ($906,288)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
Page 4 of 11 · 208 filings